Molecular Partners Ag

MOLN chart

Molecular Partners Ag news

• Molecular Partners AG Estimates – NASDAQ:MOLN

  TradingView · Oct 23, 9:40 AM EDT

• Molecular Partners selects MP-0730 as radiotherapeutic candidate

  BioWorld News · Oct 22, 9:00 AM EDT

• Molecular Partners Nominates MP0730 as Next Candidate in Expanding Pipeline of Radiotherapeutics, Targeting CD70

  Yahoo Finance · Oct 22, 1:00 AM EDT

• Molecular Partners AG Selects MP0730 As Its Lead Radio-DARPin Candidate Targeting CD70

  www.marketscreener.com · Oct 22, 1:00 AM EDT

• In mice, a radioactive cancer candidate showed sustained tumor uptake relative to healthy tissues.

  Stock Titan · Oct 22, 1:00 AM EDT

• Molecular Partners Reports H1 2026 Financial Results and Corporate Highlights: DLL3 Radiotherapy MP0712 Successfully Advancing to Higher Dose Level in Phase 1/2a Study

  Yahoo Finance · Aug 25, 1:00 AM EDT

• Molecular Partners Announces Clinical Progress in Phase 2 TACTIC Combination Trial of MP0317 for Patients with Cholangiocarcinoma

  Yahoo Finance · Jul 16, 1:00 AM EDT

• Molecular Partners Showcases Bispecific Radio-DARPins at Gordon Research Conference

  Yahoo Finance · Jul 15, 1:00 AM EDT

• Molecular Partners Updates on Clinical Progress Across Expanding Pipeline of DARPin Radiotherapeutics

  Yahoo Finance · Jul 6, 1:00 AM EDT

• Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712

  Yahoo Finance · Jul 2, 1:00 AM EDT

• European Penny Stocks To Watch In June 2026

  Yahoo Finance · Jun 10, 2:04 AM EDT

• Molecular Partners Holds Presentations at ASCO and SNMMI 2026 on DLL3-Targeting Radio-DARPin MP0712, Now Dosing Patients in Phase 1

  Yahoo Finance · May 30, 8:00 AM EDT

Molecular Partners Ag key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-K6-K2026-08-25
• 6-KFORM 6-K2026-07-20
• 6-KFORM 6-K2026-07-07
• 6-KFORM 6-K2026-07-02
• 6-KFORM 6-K2026-06-01
• 6-K6-K2026-05-12
• 6-KFORM 6-K2026-05-01
• 6-KFORM 6-K2026-04-14
• 6-K6-K2026-03-30
• 6-KFORM 6-K2026-03-13
• 6-K6-K2026-03-12
• 20-F20-F2026-03-12

About Molecular Partners Ag

Ticker

MOLN (Nasdaq)

Industry

Biological Products, (No Diagnostic Substances)

Headquarters

Schlieren-Zurich, Switzerland

Incorporated in

Switzerland

Fiscal year end

December 31

SEC CIK

1745114

Frequently asked questions